ClinicalTrials.gg
Status unknownNCT02037451Updated Jan 16, 2014

The Effects of Auditory Cueing on Rhythmic Movement and Cortical Excitability in Patients With Parkinson's Disease

An interventional study of rhythmic auditory stimulation in Parkinson's Disease, sponsored by Chang Gung University. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2014-01-16.

Sponsored by Chang Gung University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

Parkinson's disease (PD) is a progressive degenerative disease of central nervous systems deficit. The clinical symptoms of Parkinson's disease include the following motor tasks: difficult in initiating movement, performing rhythmic movement or serial movement, the ability of learning motor movement is also affected. The primary treatment for Parkinson's disease is medical treatment; surgery is used if in need. Rehabilitation such as physical therapy, which aims to improve patient's quality of life and functions, is a non-invasive treatment and value for PD patients. Auditory cue is a technique that widely applied on training patients with Parkinson's disease, and some researches revealed that auditory cueing could improve motor performance. However, the mechanism under this treatment technique is still unknown.

This study is to investigate the effect of auditory cueing on rhythmic finger movement in patients with Parkinson's disease. To investigate the mechanism under auditory cueing, neurophysiological data such as motor cortex excitability and blood flow in cortical cortex will be obtained by using Transcranial magnetic stimulation (TMS) and near infrared spectroscopy (NIRS).

02

Conditions studied

  • Parkinson's Disease

Browse trials for

Keywords

  • Parkinson's disease
  • Auditory Cueing
03

In context

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,097 are open to participants now.

This study's planned enrollment of 38 is close to the median of 40 across 3,365 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Chang Gung University is the lead sponsor of 66 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of Parkinson disease

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of other neurological diseases
  • Dementia
  • Been diagnosed with any mental illness
  • History of seizures
  • Brain trauma
  • Body with a pacemaker or other electrical stimulator
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    intervention group

    intervention group which receive auditory cueing while performing movement

    Procedure: rhythmic auditory stimulation

  • No intervention
    Control group

    control group which performing movement after listen to required movement rhythm.

Interventions

  • Procedurerhythmic auditory stimulation

    Participants perform the finger tapping at the same time give rhythmic auditory stimulation ,and need to execute tapping with auditory stimulation.

06

What researchers measure

Primary outcomes

  1. Finger Tapping

    Record pre-test and post-test change.

    Time frame: Baseline,45-60 minutes.

  2. Motor evoked potential

    Use single-pulse TMS to assess Motor evoked potential change.

    Time frame: Baseline,45-60 minute

  3. Intracortical inhibition & Intracortical facilitation

    Use paired-pulse TMS to record pre-test and post-test change.

    Time frame: Baseline,45-60 minutes

  4. Blood oxygen dependent level

    Use Near-infrared spectroscopy to record pre-test, in experiment, and post-test change.

    Time frame: Baseline, in experiment,45-60 minutes

07

Study locations

1 of 1 sites recruiting
  • Chang Gung University
    Taoyuan, 333, Taiwan
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2013, a primary completion of Aug 2014 and a completion of Aug 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 14, 2014
First posted
Jan 16, 2014
Start
Aug 2013
Primary completionEst.
Aug 2014
CompletionEst.
Aug 2014
Last update
Jan 16, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02037451
Lead sponsor
Chang Gung University
Responsible party
Ya-Ju Chang (Profesor, Chang Gung University) — Principal investigator
First posted
Jan 16, 2014
Start date
Aug 2013
Primary completion
Aug 2014 (estimated)
Completion
Aug 2014 (estimated)
Last update
Jan 16, 2014

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion